Limited diagnostic testing can decrease the direct economic impact of irritable bowel syndrome;El escrutinio diagnóstico limitado puede disminuir el impacto económico directo del síndrome de intestino irritable (SII)

Revista Medica de Chile

Volumn 136, Issue 11, 2008, Pages 1398-1405

  Schmulson, Max J ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Diagnostic tests, routine; Direct service costs; Irritable bowel syndrome

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONSENSUS; DIGESTIVE SYSTEM EXAMINATION; ECONOMICS; HEALTH CARE COST; HUMAN; IRRITABLE COLON; MEXICO; PRACTICE GUIDELINE; STATISTICS; UNNECESSARY PROCEDURE;

CONSENSUS; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; DIRECT SERVICE COSTS; HEALTH EXPENDITURES; HUMANS; IRRITABLE BOWEL SYNDROME; MEXICO; PRACTICE GUIDELINES AS TOPIC; UNNECESSARY PROCEDURES;

EID: 62849103883     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. AGA Technical Review on Irritable Bowel Syndrome. Gastroenterology 2002; 123: 2108-31.
2. American College of Gastroenterology Functional Gastrointestinal Disorders Task Force. Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome in North America. Am J Gastroenterol 2002; 97: S1-S5.
3. Valenzuela J, Alvarado J, Cohen H, Damiao A, Francisconi C, Frugone L et al. Un consenso latinoamericano sobre el síndrome de intestino irritable. Gastroenterol Hepatol 2004; 27: 325-43.
4. López-Colombo A, Bravo-Gonzáles D, Corona-López A, Pérez-López ME, Cervantes-Ocampo M, Romero-Ogawa et al. First community-based study of functional gastrointestinal disorders (FGID) in Mexico using the Rome II modular questionnaire. (Abstract) Gastroenterology 2006; 130(Suppl 2): A508.
5. Russo M, Gaynes B, Drossman D. A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol 1999; 29: 339-43.
6. Martin R, Barron JJ, Zacher C. Irritable bowel syndrome: Toward a cost-effective management approach. Am J Manag Care 2001; 7: S268-S275.
7. Cash B, Sullivan S, Barghout V. Total costs of IBS: Employer and managed care perspective. Am J Manag Care 2005; 11: S7-S16.
8. Sandler RS, Everhart JE, Donowitz M, Adams E, Cronin K, Goodman C et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002; 122: 1500-11.
9. Schmulson M, Valdovinos MA. Utilización de recursos médicos por los pacientes con síndrome de intestino irritable en un hospital de tercer nivel. Rev Gastroenterol Mex 1998; 63: 6-10.
10. Schmulson M, Valenzuela J, Alvarado J, Cohen H, Damiao A, Francisconi C et al. Cartas al director: Consenso latinoamericano sobre el síndrome del intestino irritable: algoritmo de diagnóstico y tratamiento. Gastroenterol Hepatol 2004; 27: 635-6.
11. Spiegel BM, DeRosa VP, Gralnek IM, Wang V, Dulai GS. Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: A cost-effectiveness analysis Gastroenterology 2004; 126: 1721-32.
12. Thompson WG AND THE WORKING TEAM FOR FUNCTIONAL BOWEL DISORDERS. C. Functional bowel disorders and D. Functional abdominal pain. En: Drossman DA, Richter JE, Talley NJ, Thompson WG, Corazziari E, Whitehead WE. Editores. The functional gastrointestinal disorders. Boston: Little Brown and Company; 1994; p. 115-73.
13. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. How to read reviews and economic analyses. En: Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Editores. Clinical epidemiology, A basic science for clinical medicine. Boston: Little Brown and Co Inc; 1991; p. 379-392.
14. Longstreth GF, Wilson A, Knight K, Wong J, Chiou CF, Barghout V et al. Irritable bowel syndrome: health care use and costs: A U.S. managed care perspective. Am J Gasroenterol 2003; 98: 600-7.
15. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995; 109: 1736-41.
16. Bentkover JD, Field C, Greene EM, Plourde V, Casciano JP. The economic burden of irritable bowel syndrome in Canada. Can J Gastroenterol 1999; 13(Suppl A): 89A-96A.
17. Cash B, Schoenfeld P, Chey W. The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review. Am J Gastroenterol 2002; 97: 2812-19.
18. Spiegel BM. Do physicians follow evidence-based guidelines in the diagnostic work-up of IBS? Nature Clin Pract Gastroenterol Hepatol 2007; 4: 296-7.
19. Crean GP, Holden RJ, Knill-Jones RP, Beattie AD, James WB, Marjoribanks FM. A database on dyspepsia. Gut 1994; 35: 191-202.
20. Spiegel BM, Farid M, Esrailian E, Talley J, Chang L. Is irritable bowel syndrome a diagnosis of exclusion? A survey of primary care providers, gastroenterologists, and IBS experts. (Abstract). Gastroenterology (Suppl S2) 2006; 130: A111.
21. Drossman DA. Irritable bowel syndrome: How far do you go in the workup? Gastroenterology 2001; 121: 1512-15.
22. Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology 1997; 112: 2120-37.
23. Spiegel BM, Gralnek IM, Bolus R, Chang L, Dulai GS, Naliboff B, Mayer EA. Is a negative colonoscopy associated with reassurance or improved healthrelated quality of life in irritable bowel syndrome? Gastrointest Endosc 2005; 62: 892-9.
24. Spiegel BM, Kanwal F, Naliboff B, Mayer E. The impact of somatization on the use of gastrointestinal health-care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005; 100: 2262-73.
25. Owens DM, Nelson DK, Talley NJ. The irritable bowel syndrome: long-term prognosis and the physician-patient interaction. Ann Intern Med 1995; 122: 107-12.
26. García Rodríguez LA, Ruigomez A, Wallander MA, Johansson S, Olbe L. Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 2000; 35: 306-11.
27. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 2000; 46: 78-82.
28. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2: II43-7.
29. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
30. Gerson C, Gerson MJ, Awad RA, Chowdhury A, Dancey C, Poitras P et al. Irritable bowel síndrome: an internacional study of symptoms in eight countries. Eur J Gastroenterol Hepatol 2008; 20: 659-67.
31. Drossman DA, Weinland SR. Commentary: sociocultural factors in medicine and gastrointestinal research. Eur J Gastroenterol Hepatol 2008; 20: 593-5.